Breaking News Headlines Today

News about Johnson & Johnson

Stay current with all the latest and breaking news about Johnson & Johnson, compare headlines and perspectives between news sources on stories happening today. In total, 98 stories have been published about Johnson & Johnson which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Johnson & Johnson News

Johnson & Johnson · Los Angeles

Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders

45% Center coverage: 40 sources

See the Story

FDA · United States

OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ

Plus, news about: Hansoh, Caris-Genentech, Royalty, LIB, Greenwich LifeSciences, Gubra, J&J, Sprout, Tiziana and Vor. 💊 OrsoBio’s early obesity data: When combined with Lilly’s tirzepatide, OrsoBio’s oral obesity drug TLC-6740 led to an additional ...Johnson & Johnson Read Article

J&J Snack Foods to close 3 manufacturing sites in business revamp

100% Center coverage: 1 sources

The Icee maker expects to accrue $20 million in annualized savings from a business transformation plan aimed at simplifying production and optimizing distribution.Johnson & Johnson · United States Read Article

L.A. Jury Awards $40M in Ovarian Cancer Talc Trial; J&J Vows Appeal

Coverage: 2 sources

Myeloma Combination Cuts Line for FDA Approval After Strong ASH Results

71% Center coverage: 7 sources

J&J gains label expansion approval for Akeega in mCSPC - Pharmaceutical Technology

Akeega’s is now FDA indicated for mCSPC and mCRPC, widening the drug’s future market potential across the prostate cancer treatment landscapeJohnson & Johnson · United States Read Article

J&J's Run of Talc Lawsuit Setbacks Continues

100% Center coverage: 2 sources

A California jury has awarded $40m in damages to two women who sued Johnson & Johnson, claiming that its talc products caused ovarian cancer.Alzheimer's Disease · New York See the Story

Profits Fall by 34% to €4.47 Billion at J&J's Irish Unit

Coverage: 2 sources

Pre-tax profits at the main Irish arm of pharma giant Johnson & Johnson last year declined by 35% to €4.47 billion.Business · Ireland See the Story

Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Updated: December 14, 2025Coverage window for this report: December 8–14, 2025 Wall Street heads into the week of Dec. 15, 2025 with U.S. healthcare and pharma mega-caps back in the spotlight—pulled by three powerful forces that all intensified in the last seven days: (1) the obesity-drug arms race, (2) Washington’s policy crosscurrents around insurance subsidies and PBM transparency, and (3) a faster-moving FDA that is simultaneously accelerati…Stock Markets · United States Read Article

Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders

45% Center coverage: 40 sources

Johnson & Johnson · Los Angeles See the Story

News about Johnson & Johnson

News about Johnson & Johnson

Covered Most By

Local News Publishers

Top Johnson & Johnson News

Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders

Myeloma Combination Cuts Line for FDA Approval After Strong ASH Results

L.A. Jury Awards $40M in Ovarian Cancer Talc Trial; J&J Vows Appeal

J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell

OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ

J&J Snack Foods to close 3 manufacturing sites in business revamp

L.A. Jury Awards $40M in Ovarian Cancer Talc Trial; J&J Vows Appeal

Myeloma Combination Cuts Line for FDA Approval After Strong ASH Results

J&J gains label expansion approval for Akeega in mCSPC - Pharmaceutical Technology

J&J's Run of Talc Lawsuit Setbacks Continues

Profits Fall by 34% to €4.47 Billion at J&J's Irish Unit

Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Johnson & Johnson

J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell

OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ

J&J Snack Foods to close 3 manufacturing sites in business revamp

L.A. Jury Awards $40M in Ovarian Cancer Talc Trial; J&J Vows Appeal

Myeloma Combination Cuts Line for FDA Approval After Strong ASH Results

J&J gains label expansion approval for Akeega in mCSPC - Pharmaceutical Technology

J&J's Run of Talc Lawsuit Setbacks Continues

Profits Fall by 34% to €4.47 Billion at J&J's Irish Unit

Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders

News about Johnson & Johnson

News about Johnson & Johnson

Covered Most By

Local News Publishers Too Big Arrow Icon

Top Johnson & Johnson News

Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders

Myeloma Combination Cuts Line for FDA Approval After Strong ASH Results

L.A. Jury Awards $40M in Ovarian Cancer Talc Trial; J&J Vows Appeal

J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell

OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ

J&J Snack Foods to close 3 manufacturing sites in business revamp

L.A. Jury Awards $40M in Ovarian Cancer Talc Trial; J&J Vows Appeal

Myeloma Combination Cuts Line for FDA Approval After Strong ASH Results

J&J gains label expansion approval for Akeega in mCSPC - Pharmaceutical Technology

J&J's Run of Talc Lawsuit Setbacks Continues

Profits Fall by 34% to €4.47 Billion at J&J's Irish Unit

Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Johnson & Johnson

J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell

OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ

J&J Snack Foods to close 3 manufacturing sites in business revamp

L.A. Jury Awards $40M in Ovarian Cancer Talc Trial; J&J Vows Appeal

Myeloma Combination Cuts Line for FDA Approval After Strong ASH Results

J&J gains label expansion approval for Akeega in mCSPC - Pharmaceutical Technology

J&J's Run of Talc Lawsuit Setbacks Continues

Profits Fall by 34% to €4.47 Billion at J&J's Irish Unit

Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders

Local News Publishers